Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 15/20 | 0.54 |
| ▸ | CALCR | P30988 | 15/20 | 0.54 |
| ▸ | PLK1 | P53350 | 1/20 | 0.51 |
| ▸ | NAA50 | Q9GZZ1 | 1/20 | 0.46 |
| ▸ | APLNR | P35414 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31307235 | 0.87 | RAMP3 (0.57) | RAMP3CALCR | |
| SCHEMBL31433223 | 0.87 | MAPK8 (0.51) | RAMP3CALCRPLK1APLNR | |
| SCHEMBL31433234 | 0.86 | NAA50 (0.49) | RAMP3CALCRPLK1NAA50APLNR | |
| SCHEMBL31433221 | 0.86 | MAPK8 (0.50) | RAMP3CALCRPLK1APLNR | |
| SCHEMBL31433205 | 0.86 | NAA50 (0.49) | RAMP3CALCRPLK1NAA50APLNR | |
| SCHEMBL30438334 | 0.85 | MAPK8 (0.61) | RAMP3CALCRAPLNR | |
| SCHEMBL31315523 | 0.85 | RAMP3 (0.57) | RAMP3CALCR | |
| SCHEMBL29743019 | 0.85 | NPY2R (0.51) | RAMP3CALCRAPLNR | |
| SCHEMBL31438239 | 0.84 | NAA50 (0.51) | RAMP3CALCRPLK1NAA50APLNR | |
| SCHEMBL31410874 | 0.84 | RAMP3 (0.53) | RAMP3CALCRPLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220153783-A1 | MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES | FUSION BIOTECHNOLOGY CO., LTD. (KR) | 2022-05-19 | — | — | US | claimed |
| US-20260097092-A1 | PHARMACEUTICAL COMPOSITION CONTAINING MITOCHONDRIA-TARGETING COMPOUND AS ACTIVE INGREDIENT FOR TREATING MACULAR DEGENERATION | ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-04-09 | — | — | US | disclosed |
| WO-2024063223-A1 | PHARMACEUTICAL COMPOSITION CONTAINING MITOCHONDRIA-TARGETING COMPOUND AS ACTIVE INGREDIENT FOR TREATING MACULAR DEGENERATION | 울산과학기술원 | 2024-03-28 | — | — | WO | disclosed |
| US-20220153783-A1 | MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES | FUSION BIOTECHNOLOGY CO., LTD. (KR) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097092-A1 | PHARMACEUTICAL COMPOSITION CONTAINING MITOCHONDRIA-TARGETING COMPOUND AS ACTIVE INGREDIENT FOR TREATING MACULAR DEGENERATION | ARG2, NLN, RHOT2 | RAMP3 1169/4885CALCR 2789/4885PLK1 1172/4885 |
| US-20220153783-A1 | MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES | TFAM, HSPA9, AIFM1 | RAMP3 4247/4885CALCR 4358/4885PLK1 973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.